Vitamin B6 Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Feed, Food, Cosmetics, Pharmaceutical, Biotechnology, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 265.29 Million
CAGR (2026-2031)	5.93%
Fastest Growing Segment	Direct
Largest Market	North America
Market Size (2031)	USD 374.83 Million

Market Overview

The Global Vitamin B6 Market is projected to grow from USD 265.29 Million in 2025 to USD 374.83 Million by 2031 at a 5.93% CAGR. Vitamin B6, a group of chemically related compounds including pyridoxine, functions as an essential coenzyme for over 100 enzyme reactions involved in protein metabolism and neurotransmitter synthesis. The global market is primarily propelled by the robust expansion of the animal nutrition sector, where the nutrient is indispensable for the growth performance and feed efficiency of poultry and livestock. Additionally, rising consumer demand for preventative healthcare products drives significant consumption in the pharmaceutical and dietary supplement sectors, particularly for applications related to immune function and cognitive support.

Despite this strong demand, the market faces a critical challenge regarding supply chain over-reliance on a single production hub. According to the American Feed Industry Association, in 2024, the United States imported 94% of its Vitamin B6 supply from China. This extreme geographic concentration of manufacturing capacity renders the global market highly vulnerable to trade disputes, regulatory shifts, or logistical disruptions in the primary producing region, creating a bottleneck that can lead to severe price volatility and impede consistent market expansion.

Key Market Drivers

The Expansion of the Animal Feed and Livestock Production Sectors acts as a primary catalyst for the Vitamin B6 market, driven by the nutrient's critical role in amino acid metabolism and protein accretion essential for poultry and swine development. As commercial livestock operations intensify to meet protein requirements, the inclusion of pyridoxine in premixes has become non-negotiable for optimizing feed conversion ratios and ensuring rapid weight gain. This reliance is underscored by the sheer scale of the industry's output; according to Alltech, May 2025, in the '2025 Agri-Food Outlook', global feed production rebounded to reach 1.396 billion metric tons in 2024. Consequently, the steady rise in compound feed manufacturing directly correlates with sustained procurement volumes of feed-grade Vitamin B6, solidifying the animal nutrition segment as the dominant revenue generator.

Simultaneously, the Escalating Global Demand for Dietary Supplements and Nutraceuticals is reshaping market consumption patterns, fueling the uptake of pharmaceutical-grade Vitamin B6 for preventive healthcare applications. Consumers are increasingly turning to fortified products to address energy fatigue, cognitive health, and immune support, creating a robust sales channel independent of agricultural cycles. This trend is evident in major consumer markets; according to the Council for Responsible Nutrition, October 2024, in the '2024 Consumer Survey', 75% of Americans reported utilizing dietary supplements, maintaining a high usage rate that sustains demand for core vitamins. However, this growing consumption across both sectors interacts with supply constraints to impact market value; according to DSM-Firmenich, in 2025, Vitamin B6 prices nearly doubled over the previous year due to limited availability from manufacturers in the primary production region.

Download Free Sample Report

Key Market Challenges

The Global Vitamin B6 Market is significantly hindered by the extreme geographic centralization of its production capacity. This over-reliance on a single manufacturing hub creates a fragile supply chain where regional disruptions—ranging from regulatory changes to logistical failures—immediately trigger global shortages and pricing instability. Such volatility prevents consistent market expansion, as downstream manufacturers in the pharmaceutical and animal nutrition sectors face unmanageable risks when planning long-term production schedules or launching new product lines dependent on this nutrient.

This structural vulnerability is underscored by recent data highlighting the extent of global dependency. According to the Institute for Feed Education and Research, in 2025, China produced upwards of 80% of the global supply of vitamins utilized in critical sectors such as animal feed and pharmaceuticals. This overwhelming dominance leaves the market with virtually no buffer against supply shocks. Consequently, the inability to secure diversified sourcing options forces companies to maintain expensive safety stocks or limit their operational output, directly stifling the broader development and revenue potential of the global Vitamin B6 sector.

Key Market Trends

The Increasing Focus on Women's Health and PMS-Targeted SKUs is reshaping the Vitamin B6 market, as manufacturers leverage the nutrient’s critical role in neurotransmitter synthesis to address premenstrual syndrome and hormonal regulation. Brands are increasingly moving beyond generic multivitamins to launch condition-specific formulations that explicitly target mood fluctuations and cognitive fatigue associated with the menstrual cycle. This demographic-specific demand is evidenced by recent industry analysis; according to Glanbia Nutritionals, April 2025, in the 'Top five supplement trends for 2025' report, brain-mood health has emerged as the leading claim in new women's supplement launches globally, with 46% of products featuring this positioning.

Simultaneously, the Expansion into Functional Beverage and Food Fortification is diversifying revenue streams beyond the traditional pharmaceutical and dietary supplement sectors. This trend is driven by consumer fatigue with pill-based regimens, prompting a shift toward Vitamin B6-fortified energy drinks, savory snacks, and ready-to-mix powders that offer convenient, on-the-go nutrition. The market penetration of these formats is substantial; according to ADM, July 2025, in their report on functional food and beverage innovation, more than 70% of consumers reported consuming functional savory snacks and hot drinks weekly for health-related reasons, necessitating robust supply chains for food-grade Vitamin B6.

Segmental Insights

The Direct segment is currently identified as the fastest-growing category within the Global Vitamin B6 Market, primarily driven by a shift in procurement strategies among industrial buyers. Major entities in the pharmaceutical, food, and beverage industries are increasingly choosing to source ingredients directly from producers rather than through third-party distributors. This streamlined approach allows buyers to secure tailored product specifications and ensures tighter control over supply chain transparency. By engaging directly, manufacturers can better adhere to stringent quality standards and regulatory compliance requirements, fostering a more reliable and responsive procurement process for essential vitamin inputs.

Regional Insights

North America maintains a leading position in the global Vitamin B6 market, driven primarily by high consumer awareness regarding preventative healthcare and nutritional management. The region benefits from a robust pharmaceutical and nutraceutical sector that actively develops diverse dietary supplements to address widely prevalent lifestyle disorders. Additionally, the presence of stringent quality guidelines established by regulatory bodies, such as the U.S. Food and Drug Administration, ensures product safety and strengthens consumer trust. This combination of industrial capacity and regulatory oversight secures the region's status as a major market hub.

Recent Developments

• In November 2024, the consumer health division of Bayer expanded its presence in the Global Vitamin B6 Market with the launch of "Berocca Mind" in the United Kingdom. This new supplement was scientifically formulated to support cognitive function and mental performance, combining Vitamin B6 with Spanish sage extract, Vitamin B12, and zinc. The product introduction addressed growing consumer demand for nootropic solutions that aid memory and concentration. By integrating Vitamin B6 into this specialized formulation, the company reinforced the nutrient's critical role in energy metabolism and psychological health.
• In October 2024, Sirio Pharma introduced its "GummiBiotics" range at the CPHI Milan event, contributing to innovation in the Global Vitamin B6 Market. The new product line included "GummiBiotics Lean," a vegetarian gummy formulated with Vitamin B6, apple cider vinegar, and a specific probiotic strain to support weight management and metabolic health. This launch highlighted the increasing consumer preference for palatable, non-pill delivery formats and demonstrated the company's focus on combining Vitamin B6 with synergistic ingredients to enhance bioavailability and target specific health outcomes like body composition.
• In April 2024, Naturacare unveiled multiple new products at the Vitafoods Europe exhibition, showcasing its expanded manufacturing capabilities relevant to the Global Vitamin B6 Market. The company introduced "Bacti Serenity," a symbiotic formulation aimed at stress management that integrates Vitamin B6 with ashwagandha and probiotics to support gut-brain health. Additionally, Naturacare launched an "Electrolytes" effervescent tablet designed for sports recovery, which combines Vitamin B6 with magnesium and other B vitamins. These launches reflect the industry's move towards multifunctional health solutions that leverage Vitamin B6 for vitality and mental well-being.
• In February 2024, dsm-firmenich announced plans to separate its Animal Nutrition & Health business to mitigate exposure to volatility in the global vitamins sector. This strategic restructuring followed a period of challenging market conditions, which had previously impacted the company's vitamin operations, including the closure of a Vitamin B6 production facility in China. By isolating the animal nutrition unit, the company aimed to stabilize its earnings and focus on high-growth segments, thereby reshaping the competitive landscape of the Global Vitamin B6 Market and addressing the cyclical pressures affecting vitamin manufacturing.

Key Market Players

• Jiangxi Tianxin Pharmaceutical Co., Ltd.
• Zhejiang Xinhecheng Co., Ltd.
• dsm-firmenich
• Xinfa Pharmaceutical Co., Ltd
• Huazhong Pharmaceutical Co., Ltd.
• Roche Sanwei (Shanghai) Vitamin Co., Ltd.
• Hubei Xianning Jinghui Pharmaceutical Co., Ltd.

By Sales Channel	By End Use	By Region
Direct Indirect	Feed Food Cosmetics Pharmaceutical Biotechnology Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Vitamin B6 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Vitamin B6 Market, By Sales Channel:

• Direct
• Indirect

• Vitamin B6 Market, By End Use:

• Feed
• Food
• Cosmetics
• Pharmaceutical
• Biotechnology
• Others

• Vitamin B6 Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE